My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 340

    1.

    Trends in outpatient prescription drug costs in diabetic patients in Germany, 1994-2004.

    Rathmann W, Haastert B, Icks A, Giani G.

    Diabetes Care. 2007 Apr;30(4):848-53.PMID: 17392545 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Prescription drug use and costs among diabetic patients in primary health care practices in Germany.

    Rathmann W, Haastert B, Roseman JM, Gries FA, Giani G.

    Diabetes Care. 1998 Mar;21(3):389-97.PMID: 9540021 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study]

    von Ferber L, Köster I, Hauner H.

    Med Klin (Munich). 2006 May 15;101(5):384-93. German. PMID: 16685485 [PubMed - indexed for MEDLINE]Related articles

    4.

    [Prescribing behavior of primary care physicians in diabetes therapy: effect of drug budgeting]

    Jünger C, Rathmann W, Giani G.

    Dtsch Med Wochenschr. 2000 Feb 4;125(5):103-9. German. PMID: 10705882 [PubMed - indexed for MEDLINE]Related articles

    5.

    Evaluation of drug usage and expenditure in a hospital diabetes clinic.

    Wu SY, Lung BC, Chang S, Lee SC, Critchley JA, Chan JC.

    J Clin Pharm Ther. 1998 Feb;23(1):49-56.PMID: 9756112 [PubMed - indexed for MEDLINE]Related articles

    6.

    Incremental prescription and drug costs during the years preceding diabetes diagnosis in primary care practices in Germany.

    Icks A, Haastert B, Giani G, Rathmann W.

    Exp Clin Endocrinol Diabetes. 2006 Jul;114(7):348-55.PMID: 16915536 [PubMed - indexed for MEDLINE]Related articles

    7.

    Nationwide survey of comorbidity, use, and costs of all medications in Finnish diabetic individuals.

    Reunanen A, Kangas T, Martikainen J, Klaukka T.

    Diabetes Care. 2000 Sep;23(9):1265-71.PMID: 10977017 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Structure and costs of health care of diabetic patients in Finland.

    Kangas T, Aro S, Koivisto VA, Salinto M, Laakso M, Reunanen A.

    Diabetes Care. 1996 May;19(5):494-7.PMID: 8732715 [PubMed - indexed for MEDLINE]Related articles

    9.

    Drug therapy of cardiovascular risk factors: guidelines versus reality in primary health care service.

    Marković BB, Kranjcević K, Reiner Z, Blazeković SM, Spehar SS.

    Croat Med J. 2005 Dec;46(6):984-9.PMID: 16342354 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Trends in the prescription and cost of diabetic medications and monitoring equipment in England 1991-2004.

    Patel H, Srishanmuganathan J, Car J, Majeed A.

    J Public Health (Oxf). 2007 Mar;29(1):48-52. Epub 2006 Nov 23.PMID: 17124257 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The prevalence and cost of diabetes in metropolitan France: what trends between 1998 and 2000?*.

    Ricordeau P, Weill A, Vallier N, Bourrel R, Schwartz D, Guilhot J, Fender P, Allemand H.

    Diabetes Metab. 2003 Nov;29(5):497-504.PMID: 14631326 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The cost burden of diabetes mellitus: the evidence from Germany--the CoDiM study.

    Köster I, von Ferber L, Ihle P, Schubert I, Hauner H.

    Diabetologia. 2006 Jul;49(7):1498-504. Epub 2006 May 11.PMID: 16752168 [PubMed - indexed for MEDLINE]Related articles

    13.

    The impact of diabetes on prescription drug costs: the population-based Turin study.

    Bruno G, Karaghiosoff L, Merletti F, Costa G, De Maria M, Panero F, Segre O, Cavallo-Perin P, Gnavi R.

    Diabetologia. 2008 May;51(5):795-801. Epub 2008 Mar 4.PMID: 18317724 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Drug prescribing in primary health care for diabetic and non-diabetic patients: effect of therapeutic drug budgeting]

    Jünger C, Rathmann W, Giani G.

    Gesundheitswesen. 1999 Dec;61(12):607-13. German. PMID: 10666939 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Costs of type 2 diabetes in Germany. Results of the CODE-2 study]

    Liebl A, Neiss A, Spannheimer A, Reitberger U, Wagner T, Görtz A.

    Dtsch Med Wochenschr. 2001 May 18;126(20):585-9. German. PMID: 11402924 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Heterogeneity of costs of diabetic patients: the Cost of Diabetes Mellitus Study]

    Köster I, Hauner H, von Ferber L.

    Dtsch Med Wochenschr. 2006 Apr 13;131(15):804-10. German. PMID: 16607599 [PubMed - indexed for MEDLINE]Related articles

    17.

    Determinants of diabetes-attributable non-blood glucose-lowering medication costs in type 2 diabetes: the Fremantle Diabetes Study.

    Davis WA, Knuiman MW, Hendrie D, Davis TM.

    Diabetes Care. 2005 Feb;28(2):329-36.PMID: 15677788 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Prescription of insulin glargine in primary care practices in Germany.

    Rathmann W, Haastert B, Riebel P, Schroeder-Bernhardi D, Kostev K, Huppertz E, Giani G.

    Exp Clin Endocrinol Diabetes. 2007 Apr;115(4):252-6.PMID: 17479442 [PubMed - indexed for MEDLINE]Related articles

    19.

    Rapid increase in the use of oral antidiabetic drugs in the United States, 1990-2001.

    Wysowski DK, Armstrong G, Governale L.

    Diabetes Care. 2003 Jun;26(6):1852-5.PMID: 12766122 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Health care costs and medication adherence associated with initiation of insulin pen therapy in medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.

    Pawaskar MD, Camacho FT, Anderson RT, Cobden D, Joshi AV, Balkrishnan R.

    Clin Ther. 2007;29 Spec No:1294-305.PMID: 18046929 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity